Skip to main content

Table 1 Patients’ demographic and clinical variables distribution

From: Prescribing pattern of anti-psychotic medications in patients with dementia in Oman: a retrospective observational study

Variables

n (%)

Age group

 60–65 years

38 (15.1)

 66–75 years

103 (41.0)

 76–85 years

83 (33.1)

 > 85 years

27 (10.8)

Age during prescribing anti-psychotic (mean±sd)

74.43±8.62

Gender

 Male

108 (43.0)

 Female

143 (57.0)

Marital status

 Single

3 (1.2)

 Married

177 (70.5)

 Divorced

13 (5.2)

 Widow/widower

58 (23.1)

Region

 Muscat

106 (42.2)

 Outside Muscat

145 (57.8)

Educational level

 Illiterate

22 (8.8)

 High school graduate

4 (1.6)

 High school diploma

13 (5.2)

 Bachelor’s degree

6 (2.4)

 Unknown

206 (82.1)

Severity of dementia

 Mild stage

64 (25.5)

 Moderate stage

71 (28.3)

 Severe stage

116 (46.2)

Duration of anti-psychotic use

 No anti-psychotic prescribed

109 (43.4)

 Anti-psychotic prescribed

142 (56.6)

  <1 year

21 (8.4)

  1–2 years

32 (12.7)

  >2 years

77 (30.7)

  Unknown duration

12 (4.8)

Anti-dementia agents used, besides anti-psychotic

 ChEI

169 (67.3)

 ChEI + NMDA antagonist

10 (4.0)

 NMDA antagonist

11 (4.4)

 No anti-dementia agent used

61 (24.3)

  1. chEI cholinesterase inhibitor drugs, NMDA antagonist N-methyl-D-aspartate receptor antagonists